Currax Pharmaceuticals
在场
Currax Pharmaceuticals 是一家在股票代码 OREX (US) 下上市的公司。
高管
查看带有其 8 名主要高管的组织结构图
Currax Pharmaceuticals 搜索最多的简介
- George Hampton, Chief Executive Officer
- Aaron Chesnut, Vice President, Technical Operations
- Michael Kyle, Senior Vice President and Chief Medical Officer
创建提醒
跟踪 Currax Pharmaceuticals 的高管变动
药店
Currax Pharmaceuticals 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Currax Pharmaceuticals 的最新新闻稿
- Currax — Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
- Currax — Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
- Currax — Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
- Currax — Currax™ Holdings USA LLC Announces Launch and Close of Acquisition
通过电子邮件
